Press Release
| PSP001 (PEGIL29 Chimera) IND submission (FDA) |
| Date:2021-02-05 17:07:25 | Visits： |
|
| Prev:Dr. Hongyu Liu, CEO of Prosit Sole Biotechnology (Beijing) attended the Hong Kong Summit of Winner of Nobel Prize and Turing Award at International Center of Innovative Technology, as a leader of inno Next:PSP001 received Safe-to-proceed Letter by FDA |
